Core Viewpoint - The Hong Kong Hang Seng Index closed up 0.68% at 24,994.14 points, reaching a new high since February 2022, with significant contributions from state-owned enterprises [1] Group 1: Market Performance - The Hang Seng Index briefly surpassed the 25,000 points mark during trading [1] - The AH premium decreased by 0.67% to 125.44, marking the lowest level since June 2020, indicating a narrowing price gap between H-shares and A-shares [2] Group 2: Stock Movements - Major state-owned enterprises led the gains in the Hang Seng Index, with China Petroleum & Chemical Corporation rising by 5.53%, China National Petroleum Corporation by 3.61%, and China Shenhua Energy Company by 2.94% [1] - Several companies related to the Yarlung Tsangpo River hydropower project saw significant stock price increases, with Huaxin Cement, Dongfang Electric, and Chongqing Iron & Steel achieving daily price limits in A-shares, while their H-shares surged by 85.63%, 65.21%, and 25.53% respectively [2] Group 3: AH Share Premiums - As of July 21, the number of AH companies with H-shares priced higher than A-shares increased to 8, with CATL showing the highest premium of 36.69% [3] - Other companies with significant premiums included Huaxin Cement (17.99%), Dongfang Electric (14.84%), and Hengrui Medicine (14.1%) [3] Group 4: Market Trends and Outlook - The AH premium has remained low for the past month, with only 3 companies previously showing H-shares priced higher than A-shares [4] - Despite challenges such as external tariff pressures and a weakening domestic growth cycle, the Hong Kong market remains active, with a daily average trading volume of 2,406 million HKD, an increase of over 80% from 2024 [4] - The influx of southbound capital has also been robust, with an average daily inflow of 61.5 million HKD, nearly double the 34.7 million HKD from 2024 [4] Group 5: IPO and Market Dynamics - The number of companies listing in Hong Kong is increasing, with 10 A-share companies converting to H-shares, raising 70% of their funds from this transition [5] - Short-term AH premiums are constrained by a "hidden floor" due to dividend tax arrangements, while long-term macro factors supporting Hong Kong's capital market remain unchanged [5]

Core Viewpoint - The inclusion of companies listed in both A-share and H-share markets (A+H companies) in the Hong Kong Stock Connect is increasing, reflecting a growing trend of A-share companies seeking to list in Hong Kong and the positive market response to these listings [1][11][12]. Group 1: Recent Developments - On July 21, the Shenzhen Stock Exchange announced the adjustment of the Hong Kong Stock Connect eligible securities list, adding Sanhua Intelligent Control, which has recently completed its listing on the Hong Kong Stock Exchange [1][4]. - This year, several A+H companies, including Chifeng Jilong Gold, Junda Co., Ningde Times, and others, have been added to the Hong Kong Stock Connect [2][7]. Group 2: Market Trends - As of July 18, 156 out of 160 A+H companies have been included in the Hong Kong Stock Connect, accounting for 28% of all eligible securities [8]. - The trend of A-share companies listing in Hong Kong has been on the rise, with 10 companies having completed listings in Hong Kong this year alone [12][14]. Group 3: Regulatory Environment - Regulatory improvements have been a significant driver for A-share companies to list in Hong Kong, including measures from the China Securities Regulatory Commission to expedite the approval process for companies seeking to list abroad [15]. - The Hong Kong Stock Exchange has also introduced measures to attract A-share companies, such as a fast-track review process for companies with a market capitalization exceeding HKD 10 billion [15]. Group 4: Market Dynamics - Unlike previous trends where H-share prices were lower than A-share prices, many A+H companies have seen their H-share prices exceed A-share prices this year, boosting confidence in A-share companies listing in Hong Kong [17]. - As of July 18, 155 A+H companies have a premium on their H-shares compared to A-shares, indicating a shift in market dynamics [18].

Core Viewpoint - Anker Innovations is exploring equity financing in the Hong Kong capital market, reflecting a growing trend of A-share companies listing in Hong Kong, with 10 companies having done so by July 17 this year [1] Group 1: A-share Companies Listing in Hong Kong - There has been a surge in A-share companies listing in Hong Kong, with 41 companies currently processing their listing applications as of mid-July [4] - The increase in A-share companies seeking to list in Hong Kong is attributed to policy support and the need for companies to expand their financing channels and international presence [4][6] - The Hong Kong IPO market has seen significant activity, with the total fundraising amount leading globally in the first half of the year [4] Group 2: Characteristics of Newly Listed A+H Companies - The newly listed A+H companies in Hong Kong this year are characterized by high market capitalization, with 9 out of 10 having a market value exceeding 10 billion yuan, and 5 exceeding 100 billion yuan [7] - These companies have demonstrated strong dividend capabilities and a focus on technology, enhancing their influence on the Hong Kong market [7] - A significant portion of the A+H companies are state-owned enterprises, with 68.13% of the 160 A+H companies being state-owned as of July 17 [7] Group 3: AH Share Premium Trends - The AH share premium has been on a downward trend, with 96.88% of A+H companies showing a premium of A-shares over H-shares as of July 17 [8] - The Hang Seng Shanghai-Shenzhen-Hong Kong Stock Connect AH share premium index was reported at 127.65, indicating that A-shares are, on average, 27% higher than H-shares [8] - The decline in AH share premium is attributed to differences in investor structure and trading mechanisms between A-shares and H-shares [8][9] Group 4: Future Outlook - It is anticipated that the trend of A-share companies listing in Hong Kong will continue over the next 2 to 3 years, supported by ongoing regulatory optimizations and market synergies [5][6] - The AH share premium is expected to continue narrowing, with factors such as increased southbound capital inflow and improved market conditions contributing to this trend [9]

Core Viewpoint - The recent focus in the market is the narrowing of the AH share premium, with UBS indicating that unless there is a significant influx of additional liquidity into the A-shares, the AH premium will remain at its current low mid-range levels [1] Group 1: AH Share Premium Dynamics - UBS statistics show a high correlation coefficient of 0.83 between the AH share premium and the US dollar index over the past 15 years, suggesting that a weaker dollar typically leads to a narrower AH premium, indicating better performance of H-shares relative to A-shares [1] - The changes in the AH share price differential are largely influenced by the liquidity differences between onshore and offshore markets [1] Group 2: Impact of Dollar Fluctuations - During periods of a weaker dollar, global liquidity tends to improve, resulting in capital inflows into emerging markets, and vice versa [1] - Despite the narrowing premium, UBS believes that A-shares will still benefit moderately from a slight strengthening of the RMB against the USD when the dollar declines [1] Group 3: Emerging Market Performance - UBS estimates that over the past decade, a 10% decline in the US dollar index has led to a relative increase of 9% in emerging market equities [1] - From a profitability perspective, Chinese companies with significant costs tied to imports or heavy dollar-denominated debt exposure are likely to benefit from a weaker dollar [1]

Group 1 - The A-share market shows signs of recovery, with the Shanghai Composite Index surpassing 3,500 points, attracting attention to foreign capital movements, particularly northbound funds [1] - As of the end of Q2 2025, northbound funds held a total of 2,907 A-shares, with a total shareholding of 1,232.08 billion shares, an increase of 41.19 billion shares from the previous quarter and 7.22 billion shares from the end of 2024 [2] - The total market value of northbound funds reached 2.289 trillion yuan, an increase of 537 billion yuan from the previous quarter and 871 billion yuan from the end of 2024, indicating a significant increase in investment in the A-share market [2] Group 2 - The industry with the largest increase in shareholding by northbound funds in Q2 2025 was enterprise services, with a growth of 38%, followed by telecommunications services at 27% and national defense at 26% [2] - Conversely, the industries with the largest decrease in shareholding were hardware equipment, down 15%, and home appliances and textiles, both down 13% [2] Group 3 - The stocks with the highest market value held by northbound funds as of June 2025 included CATL, Kweichow Moutai, Midea Group, and others, with CATL and Kweichow Moutai each exceeding 100 billion yuan in market value [3] - The three companies with the most significant changes in market value held by northbound funds were CATL, Hengrui Medicine, and Dongpeng Beverage, all of which have recently listed on the Hong Kong Stock Exchange [3][4] Group 4 - The decline in AH share premiums indicates a narrowing price gap between A-shares and H-shares, enhancing market efficiency and providing a fairer investment environment [5][7] - The decrease in AH share premiums may influence the allocation of northbound funds between A-shares and H-shares, shifting focus towards the fundamentals and industry outlook rather than short-term price differences [7][8]

Core Viewpoint - The Hong Kong stock market has experienced a decline, with the Hang Seng Index dropping by 1.06% and the Hang Seng Tech Index falling by 1.76% in July, while A-shares have been rising, leading to a rebound in the AH share premium [1] Group 1: Market Performance - The Hang Seng Index and Hang Seng Tech Index recorded declines in July, contrasting with the upward trend in A-shares, particularly the Shanghai Composite Index approaching 3500 points [1] - As of July 9, the AH share premium has rebounded to 130.64, an increase of over 2% from mid-June [1] Group 2: Individual Stock Performance - Among the 160 AH shares, only three companies—CATL, Hengrui Medicine, and WuXi AppTec—are trading at a premium for their H-shares compared to A-shares, with CATL's premium exceeding 30% and Hengrui Medicine's over 11% [1][2] - CATL's H-shares have risen nearly 17% in July, while its A-shares increased by 7.37%, leading to an expanding premium [2][3] - Hengrui Medicine's H-shares have surged over 29% since their listing on May 23, while A-shares rose by 10.19%, resulting in a significant premium for H-shares [3] Group 3: Market Dynamics - The market dynamics indicate that CATL and Hengrui Medicine are core assets in the domestic new energy and innovative drug sectors, attracting significant capital in the Hong Kong market [3] - The liquidity of H-shares for both companies is considerably lower than that of A-shares, making it easier to drive up H-share prices [4] Group 4: Recent Developments - CATL has signed a comprehensive electrification deepening strategic cooperation agreement with Geely Auto, focusing on battery technology collaboration and supply chain development [4] - Hengrui Medicine has received approval for clinical trials of two new drugs, with one targeting chronic obstructive pulmonary disease (COPD), indicating a strong pipeline of innovative drugs [5]

Market Overview - The equity market experienced fluctuations last week (June 9 to June 13, 2025), with a decline in risk appetite due to external events. The average daily trading volume for the entire A-share market was 1.3716 trillion, continuing to rise week-on-week, driven mainly by event-related trading, with sectors like non-ferrous metals, oil and petrochemicals, and agriculture leading the gains [2][13]. AH Share Premium - The AH share premium index fell to a low level of 128 points, breaking below the previous lows of January 2023 and October 2024, placing it in the 0.8% percentile over the past five years. The Hang Seng Index has risen by 19.11% year-to-date, with recent trends indicating that the inflow of southbound capital has slowed, focusing more on sectors with significant gains [3][13]. Banking Sector Performance - The banking sector achieved excess returns, with the banking index rising by 0.67% last week, outperforming the CSI 300 index, which fell by 0.21%. Since May, the banking sector has generated an excess return of 6.21% compared to the CSI 300. Despite overall performance pressure, banks maintained a return on equity (ROE) above 10%, highlighting their stability and dividend certainty [14]. Technology Sector Activity - The technology sector saw a resurgence in trading activity, with its trading volume share increasing to 29.21% in June, following a decline to 25.8% in May. The sector experienced internal differentiation and rotation, with high external demand and performance recovery in areas like computing and optical modules [15]. Public Fund Market Dynamics - On June 11, the Shanghai Stock Exchange held a seminar to discuss the development of index investment in the Sci-Tech Innovation Board, focusing on the construction of a high-quality investment ecosystem for long-term investments. The board has established various indices, including the Sci-Tech 50 and industry-specific indices [16][17]. Active Equity Fund Index Performance - The active equity fund indices showed varied performance last week, with the active stock fund index rising by 0.60%, the value stock fund index up by 0.68%, and the growth stock fund index increasing by 0.76%. The medical stock fund index had a notable rise of 4.72%, reflecting strong performance across different sectors [4][5][7][8].

Core Viewpoint - The recent trend of leading A-share companies listing on H-shares is gaining momentum, with several companies successfully completing their listings in Hong Kong, enhancing their international market presence and brand recognition [1][2]. Group 1: H-share Listing Trend - Leading companies like Midea Group, CATL, and Heng Rui Pharmaceutical have recently listed on the Hong Kong Stock Exchange, indicating a growing trend among A-share companies to seek H-share listings [1]. - Stone Technology announced its intention to list on the Hong Kong Stock Exchange, further contributing to the ongoing "H-share boom" [2]. Group 2: Investment Considerations - Investors face a dilemma regarding whether to invest in A-shares or H-shares of companies listed on both exchanges, as each market has distinct advantages and disadvantages [2]. - Analysts highlight that H-shares generally trade at a discount compared to A-shares due to differences in investor structure, liquidity, and refinancing mechanisms [3][5]. Group 3: Price Discrepancies - The long-term price discrepancy between A-shares and H-shares is attributed to the lack of free convertibility and arbitrage mechanisms between the two markets [3]. - Currently, only 155 companies are listed on both A and H-shares, representing a small fraction of the total number of companies on the Hong Kong main board [5][6]. Group 4: Sector Analysis - The majority of companies listed on both exchanges are state-owned enterprises and belong to traditional economic sectors, such as finance and energy, which tend to attract dividend-focused investors [6]. - The analysis suggests that the price differences between A and H-shares can be better understood through a dividend perspective rather than purely market sentiment [6]. Group 5: Recent Market Dynamics - The phenomenon of "A-H share price inversion" has been observed, particularly with companies like CATL, where H-shares traded at a premium to A-shares, indicating a shift in market dynamics [7][9]. - The current macroeconomic environment and differing investor preferences contribute to the observed price behaviors between A and H-shares [9][10]. Group 6: Future Outlook - Companies like Stone Technology, which have a significant portion of their revenue from overseas markets, are expected to attract foreign investment and may experience similar price dynamics as seen with CATL [12][13]. - The ongoing trend of high dividend yields in the Hong Kong market, coupled with structural opportunities in sectors like new consumption and technology, positions H-shares favorably for investors [16][17].

Group 1 - The Hong Kong IPO market has significantly recovered in 2025, with 28 new listings in the first five months, raising a total of HKD 77.36 billion, surpassing the total fundraising amount for the entire previous year [1] - The average return of newly listed stocks this year is 18%, which is 13 percentage points higher than the Hang Seng Index, and significantly better than the historical average return of 4% over three months for new stocks [1] Group 2 - Excess returns are attributed to multiple factors including improved quality of listed companies, stricter IPO approvals in mainland China, enhanced liquidity in the Hong Kong market, and foreign demand for core Chinese assets [3] - The current AH share premium is 33%, close to the ten-year average but below the five-year average, with short-term narrowing drivers including geopolitical risk alleviation and improved liquidity in Hong Kong [3] - Blue-chip A-shares listing in Hong Kong is expected to benefit from passive fund inflows, with MSCI China Index and Hang Seng Tech Index providing liquidity support for new stocks [3] Group 3 - Despite the active IPO market, the fundraising amount in Hong Kong this year is still lower than the peak in 2020 and far below the USD 53 billion southbound capital inflow [4] - H-shares have shown robust earnings performance, with the Hang Seng China Enterprises Index reporting a 7% increase in Q1 earnings and the Hang Seng Tech Index constituents increasing by 38% [4] - The AI sector is overweighted, and there is a continued positive outlook for H-shares compared to A-shares [4]

Core Insights - The Hang Seng AH Premium Index fell below 127 points on June 12, reaching a low of 126.91 points, marking a nearly five-year low with a year-to-date decline of 10.45% [1] - The AH Premium Index reflects the price differences of stocks listed simultaneously in mainland China and Hong Kong, indicating that the discount of H-shares relative to A-shares has narrowed, primarily due to H-shares outperforming A-shares [1] Summary by Sections - **AH Premium Index Performance** - The index's decline indicates a significant shift in market dynamics, with H-shares outperforming A-shares [1] - Out of 155 constituent stocks in the index, 144 H-shares have outperformed their A-share counterparts this year, representing a remarkable 93% [1] - **Notable Stock Performance** - Rongchang Biological has seen the most significant excess return, with its H-shares surging by 300% compared to a 135% increase in A-shares, resulting in a 165 percentage point excess return [1] - The AH premium for Rongchang Biological has decreased from 136% at the beginning of the year to 35% currently [1] - **Market Analysis and Future Outlook** - Analysts suggest that the re-emergence of valuation advantages in A-shares may lead to a new round of market correction, similar to historical patterns [1] - There is a growing concern regarding the long-term divergence in fundamentals between the mainland and Hong Kong markets [1]